The presence of ovarian endometriomas is associated with a reduced responsiveness to gonadotropins

Fertil Steril. 2006 Jul;86(1):192-6. doi: 10.1016/j.fertnstert.2005.12.034. Epub 2006 May 23.

Abstract

Objective: To clarify whether the presence of ovarian endometriomas is associated with a reduced responsiveness to ovarian hyperstimulation.

Design: Observational study.

Setting: University teaching hospital.

Patient(s): Women selected for in vitro fertilization-intracytoplasmic sperm injection (IVF-ICSI) cycles who were found to have unilateral ovarian endometriomas and who did not undergo previous ovarian surgery.

Intervention(s): Ovarian hyperstimulation using gonadotropins.

Main outcome measure(s): Number of codominant follicles (mean diameter >15 mm) in the affected and in the contralateral intact gonads.

Result(s): Thirty-six patients were enrolled. They underwent 56 IVF-ICSI cycles. The number of codominant follicles in the intact and affected ovaries were 4.0 +/- 2.2 and 3.0 +/- 1.7, respectively (P=.01). This difference corresponded to a mean reduction (95% confidence interval [CI]) of 25% (6%-44%). This deleterious effect was more evident in women with larger cysts, in those with more than one cyst, and in those who were more responsive to ovarian hyperstimulation.

Conclusion(s): The presence of ovarian endometriomas is associated with a reduced responsiveness to gonadotropins.

Publication types

  • Clinical Trial

MeSH terms

  • Adult
  • Comorbidity
  • Endometriosis / epidemiology*
  • Endometriosis / pathology
  • Female
  • Gonadotropins / administration & dosage*
  • Humans
  • Incidence
  • Infertility, Female / epidemiology*
  • Infertility, Female / pathology
  • Infertility, Female / prevention & control*
  • Italy / epidemiology
  • Ovarian Diseases / epidemiology*
  • Ovarian Diseases / pathology
  • Ovarian Follicle / drug effects
  • Ovarian Follicle / pathology*
  • Ovulation Induction / methods
  • Ovulation Induction / statistics & numerical data*
  • Prevalence
  • Treatment Outcome

Substances

  • Gonadotropins